Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy
Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy: A Randomized, Placebo Controlled Study
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- K. Kay Durairaj, MD, FACS, A Medical Corporation
- Participants (registry)
- 40
- Start
- March 2026
- Primary completion
- December 2026 (planned)
- Study completion
- January 2027 (planned)
- Last registry update
- September 2026
- Countries
- United States
Conditions studied: Androgenic Alopecia, Female Pattern Hair Loss, Hair Loss
Interventions: Scalp Stimulating Serum, KeraFactor Scalp Stimulating Serum, KeraFactor Serum, KeraFactor, Red Light Hair Growth Cap, Revian Red Hair Growth System, Revian Red Cap, Revian Red Wireless Smart Cap Device, Placebo scalp-stimulating serum, Placebo scalp serum, Placebo solution
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.